



Informed Consent in State-of-the-Art Medical Care 
A Narrative of a Person’s Experience of Experimental Surgery
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One of the major themes in the field of bioethics is the issue of 
informed consent, and informed choice (IC). There are a number of 
scenarios in which IC is regarded as necessary. One situation is that of 
clinical trials or experimental surgeries. One negative example of this was 
the Tuskegee Study of Untreated Syphilis in the Negro Male, which was 
conducted between 1932 and 1972. In the U.S, The Belmont Report was 
released in 1979 by a special committee to the US Congress out of regret 
over the Tuskegee Study. In Japan, Mitsuishi, Nudeshima and Kurihara, in 
2003, made tentative plans for a law to protect the subjects in scientiﬁc 
research that targets the body, some portion of it, or relevant genetic 
information. This law stipulates, regarding risks and benefits involving 
research, that there are beneﬁts that legitimate the risk to the individual 
subject and the people who experienced the same condition. It also 
stipulates that an evaluation be conducted both before and during conduct 
of the study, and that should there be any health hazards, the leader of 
the study must provide the best possible treatment. (Mitsuishi, Nudeshima, 
Kurihara 2003)
Also, improvements in the technology of decoding genetic information 
have made genetic treatment possible. As prenatal diagnoses or pre-
implantation diagnoses have become possible, and as situations have 
emerged in which genetic counseling has been requested over the 
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treatment based on the information and responses to the information 
(Tamai, Nakazawa, Abe 1997). Related to this, Wexler wrote a detailed 
description of the emotional turmoil and domestic turbulence that one 
might experience upon learning through a genetic examination the 
possibility of developing Huntington’s disease, an account based on her 
own experience as the daughter of Huntington’s disease patient and 
therefore possible inheritor of the disease (Wexler 1995).
IC issue arise medical treatment scenarios, especially in the case 
of difficult diseases such as ALS or cancer. It is difficult for doctors to 
determine when a doctor should inform the patient of a disease’s name 
and how treatment should be done. Diﬃcult problems have also arisen in 
cases of Jehovah’s Witnesses who refused blood transfusion for religious 
reasons.
IC is regarded as the provision of information on the risks and 
benefits, the existence or nonexistence of decision making faculties, the 
patients’ right to make their own decisions and the problems of protecting 
subjects. However, there are few studies dealing with experiences of IC, 
particularly there was been little reasons on what sort of experiences 
people have with IC in clinical researches on human subjects in state-
of-the-art experimental medical treatment. In this presentation, we will 
consider a narrative about IC in the first domestic study osteo-odonto-
keratoprosthesis (OOKP) conducted in 2003.
II　Subjects and methods
The subject was Ms. Tachibana (assumed name). She was born in 
1952, as the last child of four siblings. She had no experience of serious 
illness. However, at the age of 44 (1998), she had Stevens-Johnson 
syndrome (SJS)（1,2） and all of a sudden became nearly blind. Then at the 




Methods: The author conducted series of interviews with Ms. 
Tachibana in 2005 and 2006（5）. The author abstracted from Ms. 
Tachibana’s interview, her narrative about the explanation of the surgery 
given before the operation. This was then divided into a narrative of the 
doctor’s explanations and Ms. Tachibana’s reaction about the explanation 
(Table 1). Next, the author extracted her narrative about her condition 
after the surgery. Then the author looked at the advantages and 
disadvantages resulting from the surgery (Table 2)（6）. The author then 
reorganized Ms. Tachibana’s narratives about IC and described them. In 
doing so, the author described her narrative using quotations from Ms. 
Tachibana’s account to highlight her understanding and evaluation of the 
IC and the surgery.
III　Results
Table 1 Ms. Tachibana’s understanding of the doctor’s explanation of 
operation before surgery, and her reaction to it
Ms. Tachibana’s understanding 
of the explanation
Ms. Tachibana’s reaction to the explanation
My left eye will become pink. →
If the surgery fails, then [I] won’t be 
able to see and me eye will be pink. A 
total disaster. But the change of eye 
color will not matter to me.
My ﬁeld of vision will be narrow. → It was beyond my imagination.
My eyelids will not close, so 
I won’t be able to blink.
→ It was beyond my imagination.
My iris will be removed → It was beyond my imagination.
They will pullout the tooth 
from the root bone, and then 
insert a lens into it.
→ It was beyond my imagination.
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There is only one cuspid left 
that can be used because one 
cuspid is decayed and the 
other two are implants.
→
I had better do this now while there is 
still a tooth left, so there is no time but 
now.
I think the doctor told me 
that my visual acuity would 
reach an average of 0.7 to 0.8
→ 　
The success rate of the 
surgery is high.
→
Even if the success rate is high, there is 
still the possibility of failure. Therefore 
I can’t but think about the possibility 
of failure, so I don’t like being the ﬁrst 
person for this kind of surgery. 
New techniques being used 
at other universities are not 
appropriate for me.
→
If I get the surgery, this is the only 
technique for my case.
Table 2　Advantages and disadvantages brought about by the 
restoration of vision through OOKP
[Advantages]
・ Because I never thought I would see again, I will never forget when I 
ﬁrst saw again.
・I went out and traveled.
“The market and stuﬀ. Well, for example vegetables, which, of course, 
I knew about already. I would stare at them and I didn’t know why. 
Hmm, like this. Ohhh, that’s what it is. I’ll look at them again. It was 
as if I was ﬁlling in ﬁve year void. No matter what things I looked at, 
even ordinary things. Even though I was only looking at the ordinary 
things, I felt like they were something rare. When I looked at stars 
and I thought, “I can’t believe it!” or something like this.  
Because I know there were some times I couldn’t see, I am much happier 





Field of vision is narrow.
If I face a bright direction, I can see light sparking like a ring before 
my eyes.
There is glare in my vision, and I cannot see in the dark.
I have to use two diﬀerent sets of glasses, one for looking things close 
up and one for looking from afar.
Even though it is said that my vision ability is stable there is a lot of 
mucus discharge and high pressure on my eyes  high, so it is hard to 
say that my visual acuity are stabilized.
My eyelids cannot close.
When I blink, there is a weird feeling almost like winking. My right 
eye now has become droopy.
・Daily care
I can not let water in my eye , so I can not wash my face, and I also 
have to be careful when I take a bath.
Before I go to bed, I have to put salve into the eye and cover it, so 
even if I want to go to sleep, I can’t do so immediately.
Also, when I get up I have to wipe the slave oﬀ.
If I do not put the salve in, the eye hurts as if the transplanted oral 
mucous membrane and eyelids are rubbing together. If the salve on 
the edge of my eye melts and reaches the lens I can’t see anything.
If I sweat, the salve on the edge of my eye reaches the lens, and 
therefore I cannot go around so much or go out on hotter days.
I was able to move around more when I couldn’t see.
I cannot have the surgery again even if I damage my eye by hitting it 
or something, so I must always be careful.
I always wear a sun visor in order to soften any blow that might 
160
生存学研究センター報告
happen to hit my eye.
・Facial features
My face now looks like an old person’s.
My eyes do not have any expression, so it is beyond my control to say 
whether my face looks beautiful or ugly.
Since I can not wash my face, I do not put on lipstick or foundation. 
Also, I may run into people and set my make up on them.
Since I am a woman, I hate not being able to make myself up, 
although I have got used to it recently. Also, sometimes I do not like 
looking at my own face.
・Dentistry
After the tooth was removed an artiﬁcial tooth was implanted. But, 
after the oral mucus membrane was extracted, my teeth have been 
perpetually numb, plaque and tartar, and sometime I do not notice 
drooling.
・Communication with others
Due to the various factors listed above, I feel uncomfortable when 
people say to me “it’s so great that you can see again” or “you can see 
better than I.” 
I worry whether or not the person I am talking to regards me as 
disgusting and I always look down. 
I hate face-to-face situations, so I wear dark glasses so that people cannot 
see my eyes, but sometimes they can still see them due to the light.
・The social health system
Relief Money for Sufferers from Adverse Drug Reactions was 
canceled because my vision had restored.
My disability pension dropped from level 1 to level 3.
It is really frustrating that the ground of these decisions based only on 




First of all, the reason Ms. Tachibana could have this operation was 
that Ms. Tachibana said the following words to her doctor. "Even if it 
takes 5 years, or even 10 years, if there is any chance for a good operation, 
please let me know." At that time, Ms. Tachibana thought it was "like a 
kind of a joke," and she never dreamed that having such a surgery was 
possible. After a while, the doctor introduced OOKP to Ms. Tachibana. 
Not only was the OOKP operation a ﬁrst for that university hospital but 
also the ﬁrst trial within Japan. Therefore, an Institutional Review Board 
Liu Christopher, Masahiko FUKUDA, Kaichi 
SHIMOMURA, Takeshi HAMADA, 2002
Liu Christopher, Masahiko FUKUDA, Kaichi 
SHIMOMURA, Takeshi HAMADA, 2002.
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was held to approve or disapprove this surgery. The Institutional Review 
Board continued to examine the issue for approximately a year. After the 
Institutional Review Board approved this surgery, however, Ms. Tachibana 
felt that "I was worried, indeed, to decide. At least before being examined 
by the Institutional Review Board, I still didn't really know whether I 
could have the operation.”
What we should focus on here is the explanation that Ms. Tachibana 
received from the doctor, in other words, the details of the IC. The 
advantages that could be attained are two points shown in Table 1 of “I 
think the doctor told me that my visual acuity would reach an average 
of 0.7 to 0.8” and “the success rate of the surgery is high.” On the other 
hand, the risks given were that “my left eye will become pink,” “my ﬁeld 
of vision will be narrow,” “my eyelids will not close, so I won’t be able to 
blink,” “my iris was removed,” “we will pullout the tooth from the root 
bone, and then insert a lens into it,” with all of these described as “it 
was beyond my imagination.” Although Ms. Tachibana understood the 
explanations, she still said "I cannot imagine it." Even when Ms. Tachibana 
was asked by the doctor if she had any questions, the problem was that "I 
didn't even have any idea what will happen to my body."
I would like to further focus on the following thing. Although it was 
not an established treatment method, Ms. Tachibana knew that other 
treatment methods using regenerative medicine were being attempted 
at other universities at that time, and she asked whether this kind of 
surgery was appropriate for her. The response to this was “that was not 
appropriate.” This was a response as a result of the medical examination, 
so there were no problems. However, from this point, Ms. Tachibana 
thought that “if I get the surgery, this is the only technique for my case.” 
Furthermore, as a result of the oral surgical medical examination, Ms. 
Tachibana was told that “there is only one cuspid left that can be used 
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because one cuspid is decayed and the other two are implants.” This was 
also the fact that became clear as a result of the medical examination. 
However, because Ms. Tachibana only had one cuspid tooth left that could 
be used for OOKP, he thought that “I had better do this while there is still 
one cuspid left, so there is no time but now.” Therefore, Ms. Tachibana 
was driven to think that in order to be able to see again, that there were 
no other methods available other than this surgery, and that if she is to 
take this surgery then there was no time to think about it. The doctor’
s explanation was nothing more than an accurate report of the medical 
facts resulting from the medical examination, and there was no intention 
to induce Ms. Tachibana into accepting the surgery. However, as a result 
those facts effectively created this situation for Ms. Tachibana. In the 
ﬁrst place, Ms. Tachibana wanted to be able to see, and in spite of this 
wish, she was "worried whether she should take the surgery or stop the 
surgery.”
Under this situation, Ms. Tachibana had some uncertainty. In 
response to the explanation from the doctor that “the success rate is 
high,” Ms. Tachibana thought that “even if you say the success rate is 
high, there is still the possibility of failure. I can’t but think about the 
possibility of failure, so I didn’t like becoming the first person for this 
kind of surgery.” During medical consultations, Ms. Tachibana therefore 
joked by saying "doctor, why don't we quit?” and "this is bad that I'm 
the ﬁrst. I wish I could to be the second or third." In response to this, the 
doctor replied "well, somebody has to be the ﬁrst." Even if these questions 
could be discounted to some degree, Ms. Tachibana's anxiety was not a 
joke. Sometimes it is easy to ask questions in a joking form, whereas it 
is diﬃcult to ask questions talking in a serious way. Ms. Tachibana also 
felt, "for me, I thought that if I undecided about the surgery, I would have 
asked the doctor whether he would choose to suggest the surgery if his 
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wife have had the same disease" and "I wanted to ask it, but in the end I 
couldn't ask it." In relation to the questions that were never raised at any 
point, it is clear that the answers that Ms. Tachibana was seeking were 
not contained in the medical explanation, as shown in Table 1. Although, 
Ms. Tachibana needed to ask questions about various issues related to the 
operation and her life. Afterwards, in this kind of state-of-the-art medical 
treatment there was no one she could consult except for the doctor.
The reason that Ms. Tachibana decided to have the surgery was not 
only that she felt she was driven to do so. At that time, Ms. Tachibana's 
father passed away. Ms. Tachibana regretted that "I couldn't see my 
parent's face" at the time of his death. Therefore, considering that her 
mother was still in good health at the time, Ms. Tachibana thought "if her 
youngest child is in this kind of situation she would also be unhappy" and 
"I also have to stop my parent from worrying, and it is also for myself. 
In case the surgery is successful, then that would be great, and if it is a 
failure, then it just means that I can't see, and I already can't see, so I can 
then just feel that I am unlucky and should give up trying". Although Ms. 
Tachibana felt responsible to have the surgery, because it stemmed from 
her own request she had made in the ﬁrst place, she also hoped for herself 
that "I had a really strong feeling that I myself wanted to see, and that I 
wanted to see things again. It wasn't just the feeling of responsibility for 
bringing the subject up." Her children then went to ask a fortune-teller, 
and were told that if the operation were to be undertaken, it would be 
better to have surgery after the start of the New Year. Because of all 
these events, Ms. Tachibana told the doctor that she would undergo the 
OOKP surgery.
In this way, Ms. Tachibana received the operation, which was 
successful. Table 2 shows the conditions of Ms. Tachibana after the 
surgery. When the author asked Ms. Tachibana if she would have 
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undergone the operation if she had known before the surgery that she 
would end up in today’s condition, she replied, "at that time, if I knew I 
would be able to see, I would take the operation, and, well, I did take the 
surgery after all.” Therefore, her attitude probably shows her evaluation 
of Ms. Tachibana's surgery.
V　Conclusion
Since to call for medical treatment means to go for another kind 
of self, this act threatens the certainty of the current self. This is the 
context in which IC, based on the explanation of the beneﬁts and risks of a 
procedure, is conducted.
The identification of post-traumatic stress disorder (PTDS) needs 
the authenticity of memories of events that are thought to have possibly 
caused PTSD and the confirmation of which of the many events was 
actually the cause of PTSD. If we are unable to conﬁrm whether events 
that occurred in the past actually occurred, and because of the possibility 
of memories changing, even if the memories are somehow able to be 
recalled, a political battle has arisen surrounding the confirmation of 
memories in the field of authentication. In contrast, the explanation of 
beneﬁts and risks, on which IC is based, establish the memories and the 
forecasts of the future that can be estimated despite some degree of 
uncertainty, by setting certainties that are able to be measured. Therefore, 
IC, which establishes a baseline for treating uncertain events such as 
memories and forecasts as certainties, is a concept that is wrapped up 
in diﬃculties that are common to the political ﬁghting that arises when 
setting the baseline for PTSD.
If the actual events from the introduction to OOKP by the doctor 
until the surgery was accepted by Ms. Tachibana are compared to the 
idea of IC, the gap in understanding between the two would have been 
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revealed. When faced with a-state-of-the-art medical technology, a patient 
is accepting a surgery that the patient is unable to imagine, and that is 
conducted in the midst of the confusion of their everyday life, and that 
cannot be stated as the sum total of the beneﬁts and risks.
Finally, I will introduce three anecdotes. The first is that Ms. 
Tachibana, whose visually acuity was restored by the surgery, asked her 
children before the surgery to seek spiritual advice by going to the temple 
and praying for their parent. The second is that Ms. Tachibana was 
asked prior to this report to check the information contained in Tables 
1 and 2, and she saw that in Table 2 "lived comfortably" was written in 
the “advantage” ﬁeld. Ms. Tachibana asked that the item be erased. The 
third point is that the author suﬀers from after-eﬀects in the eyes due to 
Stevens-Johnson Syndrome in the same way as Ms. Tachibana, and his 
current condition is thought to be the same as Ms. Tachibana prior to 
receiving the surgery. Ms. Tachibana is aware of this fact. Therefore, each 
time Ms. Tachibana meets the author, she asks the author whether he has 
decided to take the surgery. In this way, the evaluation of accepting the 
surgery from the point of view of Ms. Tachibana is still undecided, and is 
thought to be because of the experience of accepting a surgery that could 
not be imagined.
<Notes>
（1）  Stevens-Johnson Syndrome (SJS) is the subject of the research department ﬁghting 
special disorders such as acute erythema multiforme exuditavum. The incidence 
is estimated at between 1 and 10 people per million of population, spread across a 
wide range of ages from small children to the very old. Although the causes and 
underlying mechanisms are not yet clear, SJS is thought to be a cutaneous response 
to infectious diseases and allergies. In particular, there are many cases where the 
cause is a pharmaceutical product. However, it is very diﬃcult to predict whether an 
incident will occur prior to administering a medication. Symptoms of SJS are fever, 
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repeated occurrence of erythema multiforme throughout the entire body, and the 
occurrence of inﬂammation of the mucocutaneous junctions of the lips, oral cavity, 
eyes, nose, external genitalia, etc. The prognosis is an improvement in the condition 
of the skin followed by after-eﬀects remaining in the eyes, respiratory organs, etc., 
with the possibility of death due to multiple organ damage. The mortality rate 
is 6.3 % , and for the acute form, toxic epidermal necrolysis (TEN), it is 20 to 30 % 
(Pharmaceutical and Food Safety Bureau, Japanese Ministry of Health, Labour and 
Welfare, 2005; Japan Intractable Disease Information Center, 2006).
（2）  The prognosis of corneal transplantation to treat corneal clouding arising as an 
after-effect of Stevens-Johnson Syndrome is poor, and corneal transplants have 
therefore become contraindicated. However, because it is very difficult to restore 
visual acuity by conservative treatment methods based on oral medication or 
ocular instillation, the development and establishment of surgical treatments have 
been sought, with a number of methods having been undertaken in recent years 
(Sotozono, 2000). There are two main methods of surgical rehabilitation of visual 
function for corneal disease. The ﬁrst is regenerative medicine. This is a method of 
cultured corneal epithelium transplantation using corneal epithelial stem cells that 
uses amnion and oral mucosa, and this has already been applied clinically. Another 
method is keratoprosthesis (Nakamura and Kinoshita, 2002), which includes the 
OOKP surgery that was examined in this report.
（3）  Keratoprosthesis is a method of replacing a cloudy cornea with a transparent 
prosthesis such as polymethyl methacrylate (PMMA), with the development of the 
ideas relating to modern keratoprosthesis having a history of over 200 years. The 
first time that a transplant was made into an actual human body was a quartz 
transplant by Nussbaum in 1855. From that time up to around 1900, various 
keratoprostheses were transplanted, but almost all of these were failures. Although 
the momentum for keratoprostheses temporarily dropped during the 1950s with the 
spread of corneal transplantation, the focus eventually returned with eﬀorts made to 
treat cases that had been unsuccessful by corneal transplant. Although some of the 
pioneering eﬀorts were also made in Japan starting from the 1970s, the long-term 
prognoses for all of these were poor. Within this history, in 1963 the Italian Strampelli 
reported osteo-odonto-keratoprosthesis, which uses the tooth root and alveolar 
bone from the patient to aﬃx the optical part of the keratoprosthesis. However, in 
supplementary examinations of this method carried out during the same period in 
Britain, these were almost all failures. Therefore, in 1987 Falcinelli improved the 
method of Strampelli with a method to excise the iris, lens, and anterior chamber 
of the eye when transplanting the ocular surface, and this produced good results. 
This improved method of osteo-odonto-keratoprosthesis was introduced into Italy, 
Austria, and Germany, before being introduced to Britain by C. Liu and J. Herold 
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in 1996. The number of medical cases using the improved method of osteo-odonto-
keratoprosthesis that have been reported up to now is 573, with the longest having 
an elapsed observation period of 27 years (Liu, Fukuda, Shimomura, Hamada, 2002; 
Fukuda, Liu, Shimomura, 2003; Fukuda, 2004; 2005).
（4）  OOKP consists of a ﬁrst period of surgery, which is preparatory surgery, and a 
second period of surgery that is carried out two to four months subsequently.
The ﬁrst period of surgery is carried out under general anesthesia, and consists of 
the two surgerys of A) regenerative surgery of the ocular surface, and B) implanting 
an optical component into the orbicularis oculus of the ﬁxed osteo-odonto-lamina. 
In surgery A, a sample of approximately 3 cm in diameter of the oral mucosa is 
extracted. An incision is then made into the surface of the cornea, the oral mucosa 
is sewn into the sclera, and a new ocular surface is formed. In B, a cuspid tooth 
is extracted down to the root and is shaved with a drill to create a thin wafer on 
which one side is the tooth root and the other side is bone (the osteo-odonto-lamina). 
A hole with a diameter of 3 to 4 mm is drilled through the center of the osteo-
odonto-lamina, and a cylindrical optical component made of PMMA is aﬃxed to this 
using dental cement. The reason that a cuspid tooth is used is that the root part of 
a single large tooth is required to implant the optical component. This is implanted 
into the obicularis oculus of the lower part of the eyeball opposite to the eye being 
treated. After this ﬁrst period of surgery, a delay of 2 to 4 months is made before 
the second period of surgery. This period is used to wait for granulation tissue to 
grow around the osteo-odonto-lamina, and for blood vessels to penetrate into the 
oral mucosa that was transplanted onto the ocular surface.
The second period of surgery is carried out under general anesthesia the same 
like in the ﬁrst surgery. First, the osteo-odonto-lamina that was implanted within 
the obicularis oculus during the ﬁrst period of surgery is extracted. The granulation 
tissue on the part of the tooth that will be in contact with the cornea is completely 
removed, while the excess granulation tissue on the bone part is cut away to leave a 
small amount of tissue. A U-shaped incision that is slightly larger than the diameter 
of the cornea is made into the oral mucosa of the ocular surface, and lifted and held 
down towards the bottom. The tissue of the ocular surface is cut away, the center 
is marked where the cornea will be exposed, and a 3 to 4 mm diameter section 
is cut away. In order to prevent inflammation within the eye after the surgery 
and to prevent a membrane from forming on the posterior surface of the optical 
component, the iris, lens, and anterior chamber are excised. The optical component 
of the posterior of the osteo-odonto-lamina is inserted into the incision in the cornea, 
and the lamina is sewn into the surrounding sclera and cornea. Once the sutures 
are ﬁnished, the raised part of the oral mucosa is cut away to match the size of the 
anterior of the optical component, and the optical component is protruded through 
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the incision (Fukuda, 2004; 2005).
（5）  This was an interview survey using semi-structured interviews. The interviews 
were held three times in the period between June 2005 and July 2006 (total 10 hours). 
The interviews were carried out with the permission of Ms. Tachibana and were 
recorded on minidisk.
（6）  Ms. Tachibana was asked to verify Tables 1 and 2 shown here prior to this report, 
with the tables published after adding the necessary modiﬁcations.
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